Metformin May Improve Clinical Outcomes in Comorbid Heart Failure and Diabetes
Researchers assessed the clinical outcomes of patients with comorbid heart failure and diabetes receiving treatment with metformin and sulfonylurea.
All articles by Cardiology Advisor Contributing Writer
Anemia Linked to Greater Risk for Mortality in Patients With Atrial Fibrillation
Researchers analyzed the association between anemia and CV mortality, all-cause mortality, and major bleeding in patients with atrial fibrillation.
Early Drop in Systolic BP Linked to Worse CV, Renal Function in Acute Heart Failure
Researchers examined the relationship between a drop in systolic BP, worsening renal function, and prognosis in people with acute heart failure.
No Difference in Antihypertensive Medication Dosing in Morning vs Evening
Researchers reported their findings on the effects of antihypertensive dosing in morning vs evening on patient prognosis at AHA 2021.
High Leptin Increases Mortality Risk in Stable Coronary Heart Disease
Researchers at AHA 2021 presented a study that sought to determine whether high leptin affects the risk for mortality or morbidity in patients with stable CHD.
Empagliflozin Improves Cardiovascular Outcomes for Those With CVD
Among patients with type 2 diabetes, empagliflozin showed greater benefits in patients with CVD vs without.
Cardiovascular Outcomes With SGLT2 Inhibitors in T2D Compared
A network meta-analysis was done to compare the effectiveness of SGLT2 inhibitors in participants with type 2 diabetes and cardiovascular risk factors.
DOACs and VKAs Similarly Efficacious for Black Patients vs General Population
In a landmark trial presented at AHA 2021, researchers aimed to understand the safety and efficacy of direct oral anticoagulants vs vitamin K antagonists in Black patients with non-valvular atrial fibrillation and venous thromboembolism.
ICIs Linked With Higher Risk for Cancer Therapy-Related Cardiac Dysfunction
In a study presented at AHA 2021, researchers aimed to assess the link between cancer therapy-related cardiac dysfunction and immune checkpoint inhibitors.
RAAS Inhibition Reduces Mortality in Patients With COVID-19, Pre-Existing Hypertension
A team of researchers analyzed the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on patients with COVID-19 with preexisting hypertension.
- Loading...
Loading...
Next post in Hypertension
Loading... 
Loading...